EGALET CORPORATION (EGLT)

0.01
0.00 11.76
OTC
Prev Close 0.01
Open 0.01
Day Low/High 0.01 / 0.01
52 Wk Low/High 0.00 / 0.95
Volume 328.00
Exchange OTC
Market Cap 6.24M
Div & Yield N.A. (N.A)

Latest News

4 Undervalued Biotech Stocks

4 Undervalued Biotech Stocks

Two are turnaround stories, and two are oversold.

3 Beaten-Down Biotechs That Should Head Up

3 Beaten-Down Biotechs That Should Head Up

Synergy Pharmaceuticals, Trevena and Egalet seem to have worst-case scenarios priced into them.

2 Questions From the Biotech Mailbag

2 Questions From the Biotech Mailbag

A look at how lawsuits and FDA changes could impact the industry.

Egalet Makes Friday's Biotech Mailbag

Egalet Makes Friday's Biotech Mailbag

Why the name is sagging, and what it will take to spur the sector higher.

A Biotech Trio to Like Going Into 2017

A Biotech Trio to Like Going Into 2017

Egalet, Portola Pharmaceuticals and Amicus Therapeutics hold promise for improvement.

Egalet Surges 17% but Department Stores Fall

Markets continue to meander slightly lower as we are near to closing out another trading week as the holidays approach. Egalet  is up 15% on a bounce from over-sold conditions and solid trial results from Egalet-002, a drug abuse-deterrent, extended...

Two Biopharma Names, Cara Therapeutics and Egalet, Rising

The market is extremely flat today as we hit midday. Equities are about as exciting right now as the Rams offense was just hours ago on Thursday Night Football. Two of my favorite small biopharma names, Egalet  and Cara Therapeutics , are on the way...

Biotech Hits an Inflection Point

Biotech Hits an Inflection Point

The worst appears to be over for this sector; we could see big growth ahead.

Bought Aerie Earlier? Congratulations

Bought Aerie Earlier? Congratulations

An update on some recent small biotech recommendations.

4 Small-Cap Biotechs With Big Stories to Tell

4 Small-Cap Biotechs With Big Stories to Tell

Watch these names as stability returns to the sector.